We are proud to have contributed to this publication from the COPPA Project in Argentina, led by Andrea Llera (PI), which demonstrates the feasibility and clinical value of implementing genomic sequencing for pediatric cancers in a middle-income setting. The study highlights key barriers and facilitators for scaling precision medicine in the region and underscores the role of multidisciplinary tumor boards in strengthening clinical decision-making. 

M. M.Paladino, N.Pinto, D.Verón, et al. “Challenges in Launching a Precision Pediatric Oncology Program in Argentina.” Pediatric Blood & Cancer (2026): e70290.